ReviewJournal of community genetics2026
Socio-genomics of intellectual disability in African populations: top research-producing countries.
Review in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntellectual disability (ID) is a condition that is disproportionately represented in Low-and-Middle-Income countries (LMICs), including Africa, where socioeconomic and healthcare disparities contribute to a higher burden. Although prevalence estimates suggest a greater impact in African populations than in high-income regions, data remain limited and heterogeneous. ID has a highly diverse etiology driven by a complex interplay of genetic and environmental factors that contributes to significant regional variability in its presentation.
methodsThis review aims to examine the landscape of ID research across Africa, map geographic and infrastructural disparities in publication output, diagnostic capacity, and genomic investigation.
resultsA strong geographical imbalance is noticed, with North African countries accounting for a substantial proportion of publications, while many regions remain underrepresented. Although South Africa leads overall research production, most African countries contribute minimally, and genetic studies are available for only 19 countries, often restricted to case reports. Genetic studies, frequently influenced by high rates of consanguinity in certain populations, have enabled identification of recessive variants. However, reliance on low-throughput diagnostic approaches such as karyotyping, Sanger sequencing, and gene panels limits the ability to capture the full allelic diversity and mutational spectrum of African populations.
conclusionOverall, ID research in Africa remains fragmented and uneven, shaped by socio-genomic and structural constraints. Foreign collaboration biases may inflate output without strengthening local capacity. There is a need for African-led, equitable, and decentralized initiatives using advanced genomic technologies to better define the mutational landscape and improve diagnosis, management, and care.
Indexed as
Identifiers
42911310What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.